- Name: HD PCI
- Status: Ongoing
- Study design: HD PCI is a multicenter, international, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing percutaneous coronary intervention (PCI) for non-ST elevation acute coronary syndrome (NSTEACS) or stable angina.
- Logo : No logo
- Link for more study information: Higher vs. Lower Dose Heparin for PCI – Full Text View – ClinicalTrials.gov